e-learning
resources
Virtual 2020
Pre-Congress Content
From the bronchoscope to the clinic: paediatric bronchology at a glance
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Progressive lung disease caused by ABCA3 mutation
T. Sismanlar Eyuboglu (Ankara, Turkey), T. Ramasli Gursoy (Ankara, Turkey), A. Aslan (Ankara, Turkey), Z. Onay (Ankara, Turkey), S. Pekcan (Ankara, Turkey), M. Griese (Munich, Germany)
Source:
Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Session:
From the bronchoscope to the clinic: paediatric bronchology at a glance
Session type:
E-poster session
Number:
3527
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Sismanlar Eyuboglu (Ankara, Turkey), T. Ramasli Gursoy (Ankara, Turkey), A. Aslan (Ankara, Turkey), Z. Onay (Ankara, Turkey), S. Pekcan (Ankara, Turkey), M. Griese (Munich, Germany). Progressive lung disease caused by ABCA3 mutation. 3527
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Pediatric interstitial lung disease caused by a novel ABCA3 mutation: ABCA3
G964A
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009
Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations
Source: Eur Respir J 2014; 43: 638-641
Year: 2013
Classification of different ABCA3 mutations causing interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Source: Eur Respir J 2015; 46: 474-485
Year: 2015
Lung disease caused by non-null ABCA3 mutations: long-term follow-up
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Intersitial lung disease in chlidren with mutation in the SFTPC and SFPTB gene: A two case report
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017
Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations
Source: Eur Respir J 2011; 37: 201-204
Year: 2011
Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B
Source: Eur Respir J 2011; 38: 985-987
Year: 2011
Bi-allelic missense
ABCA3
mutations in a patient with childhood ILD who reached adulthood
Source: ERJ Open Res, 5 (3) 00066-2019; 10.1183/23120541.00066-2019
Year: 2019
Sftpc mutations are a common cause of adult familial idiopathic interstitial pneumonia
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
SP-C deficiency: Three different phenotypes for the same mutation
Source: International Congress 2015 – Paediatric bronchology
Year: 2015
Lung function and disease severity in cystic fibrosis patients heterozygous for
p.Arg117His
Source: ERJ Open Res, 3 (1) 00056-2016; 10.1183/23120541.00056-2016
Year: 2017
Diffuse lung disease and pulmonary hypertension related to TBX4 mutation in 5 children
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019
A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
First heterozygous
NOP10
mutation in familial pulmonary fibrosis
Source: Eur Respir J, 55 (6) 1902465; 10.1183/13993003.02465-2019
Year: 2020
Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Homozygous mutations of ARFGAP1 gene in severe sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
SFTPA mutations in interstitial lung disease (ILD) and lung cancer
Source: International Congress 2017 – Rare diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept